After nearly two decades as a dedicated clinician, teacher and innovator at University of Chicago, Dr. Nathaniel Lloyd Crump has announced that he will be retiring on September 20th, 2019. Dr. Crump began his medical career as a medical student at Washington University, followed by his residency at University of Chicago. Dr. Crump returned to University of Chicago in 2000, after forays in California and at NorthShore University/Evanston Hospital. As Director of the Fibroid Treatment Program, Dr. Crump has been instrumental in building University of Chicago’s reputation as a leader in the management of fibroids. His clinical and research interests have centered on his passion for helping women with fibroids by investigating and employing cutting edge therapies. Dr. Crump has pioneered the minimally invasive Acessa procedure as an investigator in numerous studies leading to Acessa’s FDA approval.  He has also investigated alternatives to fibroid surgery using radiology-directed ablation. Adding to our knowledge of medical treatment of gynecologic disease, Dr. Crump has participated in Phase 3 trials of Elagolix to treat endometriosis and pelvic pain.

Dr. Crump has served in many administrative positions during his tenure at University of Chicago including Section Chief of General Obstetrics and Gynecology, Co-Director of Grand Rounds and a Member of the Diversity and Inclusion Steering Committee. Dr. Crump has mentored countless medical students and residents (including myself), who are grateful for his sharing of knowledge and expertise. Please join me in thanking Dr. Crump for his wisdom and collegiality, and wishing him well in his next chapter. We will sorely miss him.

Shari Snow, MD
Section Chief of Gynecology and Minimally Invasive Surgery
Associate Professor The University of Chicago Medicine and Biological Sciences